Stock SNOA SONOMA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Sonoma Pharmaceuticals, Inc.

Equities

SNOA

US83558L2043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.1589 USD -0.75% Intraday chart for Sonoma Pharmaceuticals, Inc. -0.06% -11.92%
Feb. 08 Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Jan. 23 Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-The-Counter Skincare Product for Daily Use CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. SNOA Stock
  4. Revisions Sonoma Pharmaceuticals, Inc.